OncoLens

OncoLens is an AI-driven oncology care platform aiming to revolutionize cancer treatment by providing multidisciplinary team collaboration, analytics, and clinical decision support tools. Founded in 2016 and based in the United States, the company offers a platform that integrates patient data from various sources, including EMRs, genomics, PACS, and pathology. This data is then used to extract actionable informatics, enabling the identification of suitable patients for clinical trials, biomarker testing, and stem cell therapies. OncoLens facilitates collaboration among multidisciplinary care teams within and across enterprises, ultimately bringing a new level of care planning to every cancer patient. In its most recent funding round on 13 July 2023, OncoLens secured investment from Cross-Border Impact Ventures. For those interested in learning more, a demo can be requested by contacting [email protected].